Skip to main content

Table 2 Acceptable empiric antibiotic treatment of SAB

From: Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial

Antibiotic

Form * (oral or iv)

Standard dose *

Frequency *

Dose adjustment *

Piperacillin + tazobactam (MSSA)

IV

4 g + 0.5 g

Every 8 h

Renal impairment

Dicloxacillin (MSSA)

Oral or IV

1 g

Every 6 h

Weight

Flucloxacillin (MSSA)

Oral or IV

1 g

Every 6–8 h

Renal impairment

Cloxacillin (MSSA)

Oral or IV

1 g

Every 6–8 h

Renal impairment

Cefuroxim (MSSA)

IV

750 mg

1.5 g

Every 6 h

Every 8 h

Renal impairment

Clindamycin (MSSA + MRSA)

Oral

600 mg

Every 6–8 h

Macrolides (MSSA)

 Claritromycin

Oral or IV

500 mg

Every 12 h

Renal and liver impairment

Vancomycin (MSSA + MRSA)

IV

1 g IV

Every 12 h

Renal impairment

Se- vanco

Linezolid (MRSA + MSSA)

Oral or IV

600 mg

Every 12 h

Rifampicin (MSSA)

Oral

300–600 mg

Every 8 h

Meropenem (MSSA)

IV

1–2 g

Every 8 h

Renal impairment

Moxifloxacin (MSSA)

Oral or IV

400 mg

Every 24 h

Aminoglycosides (MSSA)

 -Gentamycin

IV

5 mg/kg

Every 24 h

Renal impairment

  1. *Standard recommendations
  2. IV intravenous, MSSA methicillin-sensitive Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, Se-vanco serum-vancomycin